You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T1DM

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Karachi (Blood draw for insulin auto-anti body tests*)

Completed
  • Type 1 Diabetes
  • Blood draw for insulin auto-anti body tests*
  • Karachi, Sind, Pakistan
    National Institute of Child Health
Apr 21, 2022

Type 1 Diabetes Trial in San Antonio, Haifa (Pioglitazone 45 mg, Placebo)

Recruiting
  • Type 1 Diabetes Mellitus
  • Pioglitazone 45 mg
  • Placebo
  • San Antonio, Texas
  • +1 more
Feb 3, 2022

Type 1 Diabetes Trial in Chicago (Fear Reduction Intervention, Attention Control)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Fear Reduction Intervention
  • Attention Control
  • Chicago, Illinois
    University of Illinois at Chicago
May 19, 2022

Type1diabetes Trial in Boston (Very low carbohydrate diet)

Recruiting
  • Type1diabetes
  • Very low carbohydrate diet
  • Boston, Massachusetts
    Boston Children's Hospital
Nov 2, 2021

HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

Not yet recruiting
  • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
  • (no location specified)
Nov 7, 2023

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022

Type1diabetes Trial in Boston (Very low carbohydrate diet, Standard carbohydrate diet)

Recruiting
  • Type1diabetes
  • Very low carbohydrate diet
  • Standard carbohydrate diet
  • Boston, Massachusetts
    Boston Children's Hospital
Nov 2, 2021

Type 1 Diabetes Trial in Little Rock, Denver, West Des Moines (Insulin aspart SAR341402, Insulin aspart)

Completed
  • Type 1 Diabetes Mellitus
  • Insulin aspart SAR341402
  • Insulin aspart
  • Little Rock, Arkansas
  • +2 more
Apr 21, 2022

Type1diabetes Trial in London (Dexcom G6 with alert, Dexcom G6 without alert)

Completed
  • Type1diabetes
  • Dexcom G6 with alert
  • Dexcom G6 without alert
  • London, United Kingdom
    Imperial College London
Nov 11, 2021

Advanced Breast Cancer Trial in Dallas (PD-0332991 and T-DM1)

Completed
  • Advanced Breast Cancer
  • PD-0332991 and T-DM1
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 24, 2022

Breast Cancer Trial in Boston (T-DM1, Pembrolizumab)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jul 25, 2022

Hypoglycemia, Diabetes, Type 1 Trial in Chula Vista, Escondido, Renton (Dasiglucagon, Placebo)

Completed
Has Results
  • Hypoglycemia
  • Diabetes Mellitus, Type 1
  • Chula Vista, California
  • +2 more
Apr 28, 2021

Anatomic Stage IV Breast Cancer AJCC v8, HER2 Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Yuma, Arizona
  • +5 more
May 25, 2022

Diabetes, Type II, Overweight or Obesity Trial (Shake 1 then Shake 2, Shake 2 then Shake 1)

Not yet recruiting
  • Diabetes Mellitus, Type II
  • Overweight or Obesity
  • Shake 1 then Shake 2
  • Shake 2 then Shake 1
  • (no location specified)
Jul 13, 2023

T2DM Trial (SHR-3167, SHR-3167 Placebo)

Not yet recruiting
  • T2DM
  • (no location specified)
Aug 16, 2023

Type 1 Diabetes Trial in Worldwide (CFZ533, Placebo)

Recruiting
  • Type 1 Diabetes Mellitus
  • Edegem, Antwerpen, Belgium
  • +16 more
Aug 23, 2022

Hypoglycemia Trial in Germany, Slovenia, United States (dasiglucagon, , GlucaGen HypoKit)

Completed
Has Results
  • Hypoglycemia
  • Escondido, California
  • +4 more
May 31, 2021

Effect of Change in T1DM Glycemic Control Trial in Cairo (metformin, Basal/bolus insulin)

Completed
  • Effect of Change in T1DM Glycemic Control
  • Cairo, Egypt
    Nancy Elbarbary
May 6, 2021

HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • +3 more
  • (no location specified)
Dec 6, 2022

Breast Cancer Trial in Paris, Barcelone, Madrid (Trastuzumab and non-pegylated liposomal doxorubicin)

Completed
Has Results
  • Breast Cancer
  • Trastuzumab and non-pegylated liposomal doxorubicin
  • Paris, France
  • +3 more
Feb 8, 2022

HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

Completed
  • HER2-positive Breast Cancer
  • +5 more
  • Tucson, Arizona
  • +15 more
Dec 22, 2022

Type 1 Diabetes Trial in San Francisco, New Haven (PolyTregs+IL-2)

Completed
  • Type 1 Diabetes Mellitus
  • PolyTregs+IL-2
  • San Francisco, California
  • +1 more
Oct 15, 2021

Diabetes, Type 1, Type 1 Diabetes, Type 1 Diabetes Trial in Melbourne (coil-reinforced soft polymer indwelling cannula)

Completed
  • Diabetes Mellitus, Type 1
  • +3 more
  • coil-reinforced soft polymer indwelling cannula
  • Melbourne, Australia
    St Vincent's Hospital (Melbourne) Ltd - Fitzroy
Jan 25, 2021

Type 1 Diabetes Trial in United States (Siplizumab)

Not yet recruiting
  • Type 1 Diabetes Mellitus
  • Birmingham, Alabama
  • +19 more
Jan 25, 2023

HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

Active, not recruiting
Has Results
  • HER-2 Positive Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +3 more
Mar 4, 2022